Chemoresistance and chemosensitization in cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemoresistance and chemosensitization in cholangiocarcinoma

Published:2018-04 Issue:4 Volume:1864 Page:1444-1453
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Marin Jose J.G.^ORCID,Lozano Elisa,Herraez Elisa,Asensio Maitane,Di Giacomo Silvia,Romero Marta R.,Briz Oscar,Serrano Maria A.,Efferth Thomas,Macias Rocio I.R.

Funder

CIBERehd

Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain

Spanish Ministry of Economy, Industry and Competitiveness

Fundación Mutua Madrileña, Spain

Fundación Samuel Solórzano Barruso, Spain

German Research Foundation

Enrico and Enrica Sovena Foundation, Italy

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference99 articles.

1. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma;Bridgewater;J. Hepatol.,2014

2. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update;Khan;Gut,2012

3. Molecular bases of chemoresistance in cholangiocarcinoma;Marin;Curr. Drug Targets,2017

4. Molecular bases of liver cancer refractoriness to pharmacological treatment;Marin;Curr. Med. Chem.,2010

5. Further understanding of mechanisms involved in liver cancer chemoresistance;Briz;Hepatoma Res.,2017

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT/BCL-6/ABCA1 axis;Phytomedicine;2024-10

2. Cannabidiol exhibits potent anti-cancer activity against gemcitabine-resistant cholangiocarcinoma via ER-stress induction in vitro and in vivo;BMC Complementary Medicine and Therapies;2024-08-30

3. Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma;Biomolecules;2024-08-08

4. Overexpression of BubR1 Mitotic Checkpoint Protein Predicts Short Survival and Influences the Progression of Cholangiocarcinoma;Biomedicines;2024-07-19

5. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3